Equivalence Trials as Topic
"Equivalence Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about trials that aim to show a new treatment is no better and no worse than the standard treatment.
Below are MeSH descriptors whose meaning is more general than "Equivalence Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Equivalence Trials as Topic".
This graph shows the total number of publications written about "Equivalence Trials as Topic" by people in this website by year, and whether "Equivalence Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Equivalence Trials as Topic" by people in Profiles.
A Cost-Focused Alternative Cancer Medication Dispensing Strategy-"Pack Splitting". JAMA Oncol. 2019 12 01; 5(12):1691-1692.
SMART: Study protocol for a sequential multiple assignment randomized controlled trial to optimize weight loss management. Contemp Clin Trials. 2019 07; 82:36-45.
HVAD: The ENDURANCE Supplemental?Trial. JACC Heart Fail. 2018 09; 6(9):792-802.
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. Ann Oncol. 2018 05 01; 29(5):1130-1140.